Browsing Tag
David A. Ricks
8 posts
Eli Lilly commits $6.5bn to new Houston manufacturing site for small molecule APIs
Eli Lilly invests $6.5B in a Houston API facility to scale orforglipron and small molecule drugs, creating 4,600+ jobs and reshaping U.S. pharma supply.
Inside Lilly’s $50bn push to transform American drug production
Eli Lilly and Company (Lilly) has unveiled an ambitious plan to more than double its U.S. manufacturing investment,…
Eli Lilly sets 2024 revenue at $45bn amid revised guidance
Eli Lilly and Company, a leading global pharmaceutical firm, has adjusted its 2024 revenue forecast to $45 billion,…
Lilly’s $4.5bn Medicine Foundry aims to redefine how clinical trial drugs are made
Find out how Eli Lilly and Company’s $4.5bn Medicine Foundry aims to transform clinical trial manufacturing and accelerate next-generation therapies.
Lilly to invest $2.1bn in two new pharma manufacturing plants in Indiana
Eli Lilly and Company (Lilly) said that it will invest $2.1 billion to build two new pharma manufacturing…
FDA grants emergency use authorization for Bamlanivimab to treat Covid-19
The US Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for bamlanivimab (LY-CoV555), a neutralizing…
Lilly secures $375m deal with US govt for bamlanivimab Covid-19 treatment
Eli Lilly and Company (Lilly), a global pharmaceutical leader, has signed a significant $375 million agreement with the…
Lilly to build $470m pharma manufacturing plant in North Carolina
US pharma giant Eli Lilly and Company (Lilly) will build a new pharma manufacturing plant in North Carolina…